|
1
|
Boyce BF, Yoneda T and Guise TA: Factors
regulating the growth of metastatic cancer in bone. Endocr Relat
Cancer. 6:333–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roodman GD: Mechanisms of bone metastasis.
N Engl J Med. 350:1655–1664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akhtari M, Mansuri J, Newman KA, Guise TM
and Seth P: Biology of breast cancer bone metastasis. Cancer Biol
Ther. 7:3–9. 2008. View Article : Google Scholar
|
|
5
|
Coleman RE: Metastatic bone disease:
Clinical features, pathophysiology and treatment strategies. Cancer
Treat Rev. 27:165–176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YC, Sosnoski DM and Mastro AM: Breast
cancer metastasis to the bone: Mechanisms of bone loss. Breast
Cancer Res. 12:2152010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonzalez-Suarez E, Jacob AP, Jones J,
Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D and
Dougall WC: RANK ligand mediates progestin-induced mammary
epithelial proliferation and carcinogenesis. Nature. 468:103–107.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park BK, Zhang H, Zeng Q, Dai J, Keller
ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, et al: NF-kappaB in
breast cancer cells promotes osteolytic bone metastasis by inducing
osteoclastogenesis via GM-CSF. Nat Med. 13:62–69. 2007. View Article : Google Scholar
|
|
9
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimokawa N and Yamaguchi M: Molecular
cloning and sequencing of the cDNA coding for a calcium-binding
protein regucalcin from rat liver. FEBS Lett. 327:251–255. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimokawa N, Matsuda Y and Yamaguchi M:
Genomic cloning and chromosomal assignment of rat regucalcin gene.
Mol Cell Biochem. 151:157–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thiselton DL, McDowall J, Brandau O,
Ramser J, d'Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ and
Meindl A: An integrated, functionally annotated gene map of the
DXS8026-ELK1 interval on human Xp11.3-Xp11.23: Potential hotspot
for neurogenetic disorders. Genomics. 79:560–572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi M: Role of regucalcin in
maintaining cell homeostasis and function (Review). Int J Mol Med.
15:371–389. 2005.PubMed/NCBI
|
|
14
|
Yamaguchi M: Regucalcin and cell
regulation: Role as a suppressor in cell signaling. Mol Cell
Biochem. 353:101–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi M: The transcriptional
regulation of regucalcin gene expression. Mol Cell Biochem.
346:147–171. 2011. View Article : Google Scholar
|
|
16
|
Yamaguchi M: Role of regucalcin in cell
nuclear regulation: Involvement as a transcription factor. Cell
Tissue Res. 354:331–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi M: Suppressive role of
regucalcin in liver cell proliferation: Involvement in
carcinogenesis. Cell Prolif. 46:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi M: Involvement of regucalcin as
a suppressor protein in human carcinogenesis: Insight into the gene
therapy. J Cancer Res Clin Oncol. 141:1333–1341. 2015. View Article : Google Scholar
|
|
20
|
Maia C, Santos C, Schmitt F and Socorro S:
Regucalcin is under-expressed in human breast and prostate cancers:
Effect of sex steroid hormones. J Cell Biochem. 107:667–676. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murata T and Yamaguchi M: Alternatively
spliced variants of the regucalcin gene in various human normal and
tumor tissues. Int J Mol Med. 34:1141–1146. 2014.PubMed/NCBI
|
|
22
|
Yamaguchi M, Osuka S, Weitzmann MN,
El-Rayes BF, Shoji M and Murata T: Prolonged survival in pancreatic
cancer patients with increased regucalcin gene expression:
Overexpression of regucalcin suppresses the proliferation in human
pancreatic cancer MIA PaCa-2 cells in vitro. Int J Oncol.
48:1955–1964. 2016.PubMed/NCBI
|
|
23
|
Loi S, Haibe-Kains B, Desmedt C, Lallemand
F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, et
al: Definition of clinically distinct molecular subtypes in
estrogen receptor-positive breast carcinomas through genomic grade.
J Clin Oncol. 25:1239–1246. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Loi S, Haibe-Kains B, Desmedt C, Wirapati
P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, et
al: Predicting prognosis using molecular profiling in estrogen
receptor-positive breast cancer treated with tamoxifen. BMC
Genomics. 9:2392008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loi S, Haibe-Kains B, Majjaj S, Lallemand
F, Durbecq V, Larsimont D, Gonzalez-Angulo AM, Pusztai L, Symmans
WF, Bardelli A, et al: PIK3CA mutations associated with gene
signature of low mTORC1 signaling and better outcomes in estrogen
receptor-positive breast cancer. Proc Natl Acad Sci USA.
107:10208–10213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoneda T, Williams PJ, Hiraga T, Niewolna
M and Nishimura R: A bone-seeking clone exhibits different
biological properties from the MDA-MB-231 parental human breast
cancer cells and a brain-seeking clone in vivo and in vitro. J Bone
Miner Res. 16:1486–1495. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Misawa H, Inagaki S and Yamaguchi M:
Suppression of cell proliferation and deoxyribonucleic acid
synthesis in the cloned rat hepatoma H4-II-E cells overexpressing
regucalcin. J Cell Biochem. 84:143–149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamaguchi M and Daimon Y: Overexpression
of regucalcin suppresses cell proliferation in cloned rat hepatoma
H4-II-E cells: Involvement of intracellular signaling factors and
cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakagawa T, Sawada N and Yamaguchi M:
Overexpression of regucalcin suppresses cell proliferation of
cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Int J Mol Med. 16:637–643. 2005.PubMed/NCBI
|
|
30
|
Izumi T and Yamaguchi M: Overexpression of
regucalcin suppresses cell death in cloned rat hepatoma H4-II-E
cells induced by tumor necrosis factor-alpha or thapsigargin. J
Cell Biochem. 92:296–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamaguchi M, Zhu S, Weitzmann MN, Snyder
JP and Shoji M: Curcumin analog UBS109 prevents bone marrow
osteoblastogenesis and osteoclastogenesis disordered by co-culture
with breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol
Cell Biochem. 401:1–10. 2015. View Article : Google Scholar
|
|
32
|
Minkin C: Bone acid phosphatase:
Tartrate-resistant acid phosphatase as a marker osteoclast
function. Calcif Tissue Int. 34:285–290. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meijer L, Borgne A, Mulner O, Chong JP,
Blow JJ, Inagaki N, Inagaki M, Delcros JG and Moulinoux JP:
Biochemical and cellular effects of roscovitine, a potent and
selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and
cdk5. Eur J Biochem. 243:527–536. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh SV, Herman-Antosiewicz A, Singh AV,
Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R:
Sulforaphane-induced G2/M phase cell cycle arrest involves
checkpoint kinase 2-mediated phosphorylation of cell division cycle
25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cano-Abad MF, Villarroya M, García AG,
Gabilan NH and López MG: Calcium entry through L-type calcium
channels causes mitochondrial disruption and chromaffin cell death.
J Biol Chem. 276:39695–39704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Serrano-Nascimento C, da Silva Teixeira S,
Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute
inhibitory effect of iodide excess on sodium/iodide symporter
expression and activity involves the PI3K/Akt signaling pathway.
Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen QW, Edvinsson L and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smooth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Palangat M, Grass JA, Langelier MF,
Coulombe B and Landick R: The RPB2 flap loop of human RNA
polymerase II is dispensable for transcription initiation and
elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Y, Li A, Strait K, Zhang H, Nanes MS
and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass
and inhibits osteoblastic Smad activation through NF-kappaB. J Bone
Miner Res. 22:646–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamaguchi M and Sakurai T: Inhibitory
effect of calcium-binding protein regucalcin on
Ca2+-activated DNA fragmentation in rat liver nuclei.
FEBS Lett. 279:281–284. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gharibi B, Abraham AA, Ham J and Evans BA:
Adenosine receptor subtype expression and activation influence the
differentiation of mesenchymal stem cells to osteoblasts and
adipocytes. J Bone Miner Res. 26:2112–2124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Muruganandan S, Roman AA and Sinal CJ:
Adipocyte differentiation of bone marrow-derived mesenchymal stem
cells: Cross talk with the osteoblastogenic program. Cell Mol Life
Sci. 66:236–253. 2009. View Article : Google Scholar
|
|
44
|
Wu L, Cai X, Dong H, Jing W, Huang Y, Yang
X, Wu Y and Lin Y: Serum regulates adipogenesis of mesenchymal stem
cells via MEK/ERK-dependent PPARgamma expression and
phosphorylation. J Cell Mol Med. 14:922–932. 2010. View Article : Google Scholar
|
|
45
|
Laudes M: Role of WNT signalling in the
determination of human mesenchymal stem cells into preadipocytes. J
Mol Endocrinol. 46:R65–R72. 2011.PubMed/NCBI
|
|
46
|
Zaidi M, Blair HC, Moonga BS, Abe E and
Huang CL: Osteoclastogenesis, bone resorption, and osteoclast-based
therapeutics. J Bone Miner Res. 18:599–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu J, Prosperi JR, Choudhury N, Olopade OI
and Goss KH: β-Catenin is required for the tumorigenic behavior of
triple-negative breast cancer cells. PLoS One. 10:e01170972015.
View Article : Google Scholar
|
|
48
|
Li L, Zhao F, Lu J, Li T, Yang H, Wu C and
Liu Y: Notch-1 signaling promotes the malignant features of human
breast cancer through NF-κB activation. PLoS One. 9:e959122014.
View Article : Google Scholar
|
